Comment on

• HER1/EGFR inhibitor-associated rash: future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forum.

  Pérez-Soler R, Delord JP, Halpern A, Kelly K, Krueger J, Sureda BM, von Pawel J, Temel J, Siena S, Soulières D, Saltz L, Leyden J. Pérez-Soler R, et al. Oncologist. 2005 May;10(5):345-56. doi: 10.1634/theoncologist.10-5-345. Oncologist. 2005. PMID: 15851793 Review.